Selective Treatment According to Molecular Subtype of Prostate Cancer

Clinical trial NCT03696186 · UNKNOWN

Trial details

NCT number: NCT03696186
Sponsor: Tianjin Medical University Second Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer Prostate Cancer Metastatic

Start date: 2018-08-01
Primary completion: 2022-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.